AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To be a shareholder in Acuity, you need to believe in its ability to maintain a strong operational focus on innovative lighting solutions, successfully integrate recent acquisitions, and manage the ongoing risks tied to tariff pressures and market demand fluctuations. While the recent wave of increased analyst earnings estimates signals strengthening confidence, this does not materially change the current short-term catalysts or the principal risk: ongoing tariff-related marketplace uncertainty and the impact on price and margins remain key issues to watch. Among recent announcements, Acuity’s continued share buybacks stand out. The company repurchased 275,905 shares worth US$68.5 million in the latest tranche, which supports the catalyst of capital redeployment and may reflect confidence in the underlying business. However, for shareholders, this should be viewed in the context of both recent analyst optimism and the persistent risks connected to volatile supply chain costs. Yet, investors should not overlook the risk of margin compression driven by new or escalating tariffs, as there is still...
Read the full narrative on Acuity (it's free!)
Acuity's narrative projects $5.2 billion revenue and $611.0 million earnings by 2028. This requires 9.6% yearly revenue growth and a $194.0 million earnings increase from $417.0 million.
Uncover how Acuity's forecasts yield a $314.97 fair value, a 8% upside to its current price.
Four Simply Wall St Community fair value estimates for Acuity range from US$220.92 to US$422.25, showing differences of over US$200 per share. With margin pressure from tariffs still a factor, these varied views highlight the need to consider wide-ranging market scenarios.
Explore 4 other fair value estimates on Acuity - why the stock might be worth as much as 44% more than the current price!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocks
Try a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。